Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Vabysmo Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The historic and forecast growth of the Vabysmo market can be attributed to several factors. During the historic period, advancements in retinal disorder diagnosis, the proliferation of ophthalmology specialty clinics, and the success of anti-VEGF therapies contributed to the market's expansion. Additionally, an aging population and the widespread availability of intravitreal injection procedures played a role. Moving forward, growth is expected due to the increasing prevalence of diabetic eye diseases, demand for durable treatment outcomes, personalized ophthalmic care expansion, heightened investments in retinal drug development, and innovations in biologic drug delivery.
Key trends shaping the Vabysmo market forecast include the rise of long-acting retinal therapies and reduced injection frequency treatments, alongside the expansion of dual-target ophthalmic drugs. There's a growing focus on vision preservation and advanced biologic formulations. The Vabysmo market is propelled by a heightened prevalence of ophthalmic conditions, largely due to an aging global population, diabetes growth, lifestyle factors, improved detection methods, and extended lifespans. Vabysmo addresses these issues by targeting the proteins responsible for abnormal blood vessel formation and fluid leakage, enhancing vision in patients with conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME).
For example, data from the Welsh Government revealed a notable increase in ophthalmology admissions in Wales, with a 5.8% rise in 2023-24 compared to the previous year, highlighting the growing demand for ophthalmic treatments. As a specific case, the Population Reference Bureau predicts that the aging American demographic, those aged 65 and above, may surge from 58 million in 2022 to 82 million by 2050. This significant rise caused by increased life expectancy and lower birth rates underscores the importance of Vabysmo in treating retinal diseases among older adults, ultimately preventing vision loss.
A key trend involves securing regulatory approvals, allowing Vabysmo to expand its market presence. Roche Holding AG exemplifies this with their receipt of European Medicines Agency approval for Vabysmo's prefilled syringe, treating conditions such as nAMD, DME, and RVO. This innovation offers a convenient, ready-to-use option with reduced treatment burdens for retinal specialists. It works by targeting pathways like Angiopoietin-2 and VEGF-A, delivering substantial improvements in vision.
Regionally, North America led the Vabysmo market in 2025. The regions encompassed in the Vabysmo market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, with key markets in countries like the USA, UK, China, and more. However, market dynamics are influenced by tariffs impacting the cost of imported biologic materials and other resources, sparking regional manufacturing and packaging efforts.
The Vabysmo market research offers comprehensive statistics, including global market size, regional shares, competitive landscapes, detailed market segments, and prospective industry scenarios. It details the primary indications for Vabysmo, like wet AMD and diabetic retinopathy, and its forms, including injectable solutions and pre-filled syringes, distributed through multiple channels.
Overall, the Vabysmo market involves sales of syringes, preservative-free formulations, and injection goods, valued at 'factory gate' prices, encompassing related services. The market's value, defined by sales revenues within the specified geography, stands distinct from resale revenues along the supply chain.
Key Features Include:
- Market characteristics and supply chain analyses, evaluating innovation and product development trends as well as supplier dynamics.
- Emerging technology trends like digital transformation, automation, and AI-driven innovation explored in the updated strategies section.
- Regulatory insights and investment landscape overviews that inform key decision-making.
- Thorough market size forecasts considering geopolitical, economic, and technological influences, including the Russia-Ukraine conflict and trade tariffs.
- Regional and country breakdowns, highlighting shifts in supply and manufacturing globally, with an emphasis on regions such as Taiwan and Southeast Asia.
- Competitive analysis profiling major market players, highlighting significant financial deals.
- The company scoring matrix which objectively ranks major players to guide strategic business decisions.
Report Scope:
- Markets Covered: Wet Age-Related Macular Degeneration, Diabetic Macular Edema, and more.
- Formulation Categories: Injectable Solutions, Pre-filled Syringes.
- Distribution Channels: Hospital, Retail, Specialty, and Online Pharmacies.
- End Users: Adult, Geriatric.
Key Topics Covered:
1. Executive Summary
1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market
2. Vabysmo Market Characteristics
2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Vabysmo Market Attractiveness Scoring and Analysis
2.4.1. Overview of Market Attractiveness Framework
2.4.2. Quantitative Scoring Methodology
2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment and Risk Profile Evaluation
2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations
3. Vabysmo Market Supply Chain Analysis
3.1. Overview of the Supply Chain and Ecosystem
3.2. List of Key Raw Materials, Resources & Suppliers
3.3. List of Major Distributors and Channel Partners
3.4. List of Major End Users
4. Global Vabysmo Market Trends and Strategies
4.1. Key Technologies & Future Trends
4.1.1 Biotechnology, Genomics and Precision Medicine
4.1.2 Industry 4.0 and Intelligent Manufacturing
4.1.3 Digitalization, Cloud, Big Data and Cybersecurity
4.1.4 Artificial Intelligence and Autonomous Intelligence
4.1.5 Sustainability, Climate Tech and Circular Economy
4.2. Major Trends
4.2.1 Increasing Adoption of Long-Acting Retinal Therapies
4.2.2 Growing Demand for Reduced Injection Frequency Treatments
4.2.3 Expansion of Dual-Target Ophthalmic Drugs
4.2.4 Rising Focus on Vision Preservation Solutions
4.2.5 Enhanced Use of Advanced Biologic Formulations
5. Vabysmo Market Analysis of End Use Industries
5.1 Ophthalmology Clinics
5.2 Hospitals
5.3 Specialty Eye Care Centers
5.4 Adult Care Facilities
5.5 Geriatric Care Facilities
6. Vabysmo Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, and Covid and Recovery on the Market
7. Global Vabysmo Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
7.1. Global Vabysmo PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Vabysmo Market Size, Comparisons and Growth Rate Analysis
7.3. Global Vabysmo Historic Market Size and Growth, 2020-2025, Value ($ Billion)
7.4. Global Vabysmo Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)
8. Global Vabysmo Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Vabysmo Market Segmentation
9.1. Global Vabysmo Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Wet Age-Related Macular Degeneration (wAMD), Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), Uveitis, Retinal Vein Occlusion
9.2. Global Vabysmo Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable Solutions, Pre-filled Syringes
9.3. Global Vabysmo Market, Segmentation by Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies
9.4. Global Vabysmo Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adult, Geriatric
10. Vabysmo Market Regional and Country Analysis
10.1. Global Vabysmo Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Vabysmo Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/2fvozr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
